Cytiva

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody

Sunday, February 28, 2021

Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology metabolic autoimmune and other major diseases announces that the first patient outside Ch...

Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Saturday, February 27, 2021

Johnson Johnson announced that the US Food and Drug Administration FDA has issued Emergency Use Authorization EUA for its singledose COVID vaccine developed by the Janssen Pharmaceutical Companies of Johnson Johnson to prevent COVID in individuals...

Merck to Acquire Pandion Therapeutics

Thursday, February 25, 2021

Merck known as MSD outside the United States and Canada and Pandion Therapeutics Inc announced that the companies have entered into a definitive agreement under which Merck through a subsidiary will acquire Pandion

TABMELT® Granted Patent Rights in Russia, Expanding Vivera Global Licensing

Thursday, February 25, 2021

Vivera Pharmaceuticals Inc is pleased to announce the expansion of its exclusive global licensing of the novel TABMELT platform to Russia The latest TABMELT patent approval comes as the Company begins to expand its pharmaceutical offerings into neuro...

ESSA Pharma Announces Clinical Collaboration with Astellasto Evaluate the Combination of EPI-7386 and Enzalutamide forPatients with Metastatic Castration-Resistant Prostate Cancer

Thursday, February 25, 2021

ESSA Pharma Inc a clinicalstage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer todayannounced that the Company has entered into a clinical collaboration and supply agreementwith Aste...

Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti-CTLA-4 Antibody for Treatment of NSCLC and Solid Tumors

Thursday, February 25, 2021

Harbour BioMed announced that the China National Medical Products Administration NMPA has approved its Investigational New Drug IND application for HBM the next generation antiCTLA antibody in combination with PD antibodychemotherapy

Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions

Thursday, February 25, 2021

Welldoc Inc and Eli Lilly and Company announced a collaboration and licensing agreement to integrate Welldocs software into Lillys connected insulin solutions currently in development Under the terms of the agreement

Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

Thursday, February 25, 2021

Allergan an AbbVie company announced that it has submitted a New Drug Application to the US Food and Drug Administration for investigational AGN pilocarpine ophthalmic solution for the treatment of presbyopia The FDA is expected to act on the NDA by...

Zentalis Pharmaceuticals and Tempus Announce Strategic Collaboration to Advance Research and Development Capabilities

Friday, February 26, 2021

Zentalis Pharmaceuticals Inc announced a strategic collaboration with Tempus to leverage the companys patientderived organoid biological modeling platform to strengthen Zentalis discovery and research capabilities

AMRI Joins Network of Approved Manufacturers of Lipid Excipients for Pfizer-BioNTech COVID-19 Vaccine

Friday, February 26, 2021

Albany Molecular Research Inc AMRI a leading global provider of advanced contract research development and manufacturing solutions today announced that the company has been chosen to support the development and manufacture of lipid excipients for the...